New diabetes clinical trial: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Published on: January 26, 2026 at 11:00PM
Conditions: Transfusion Dependent Beta Thalassemia
Interventions: Drug: Dulaglutide 0.75Mg/0.5Ml Inj Pen; Drug: control group (insulin)
Sponsors: Ain Shams University
Completed
https://ift.tt/hlvx0Si